Acute kidney injury in patients hospitalized with COVID-19
- PMID: 32416116
- PMCID: PMC7229463
- DOI: 10.1016/j.kint.2020.05.006
Acute kidney injury in patients hospitalized with COVID-19
Abstract
The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney disease or with a kidney transplant were excluded. AKI was defined according to KDIGO criteria. Of 5,449 patients admitted with Covid-19, AKI developed in 1,993 (36.6%). The peak stages of AKI were stage 1 in 46.5%, stage 2 in 22.4% and stage 3 in 31.1%. Of these, 14.3% required renal replacement therapy (RRT). AKI was primarily seen in Covid-19 patients with respiratory failure, with 89.7% of patients on mechanical ventilation developing AKI compared to 21.7% of non-ventilated patients. 276/285 (96.8%) of patients requiring RRT were on ventilators. Of patients who required ventilation and developed AKI, 52.2% had the onset of AKI within 24 hours of intubation. Risk factors for AKI included older age, diabetes mellitus, cardiovascular disease, black race, hypertension and need for ventilation and vasopressor medications. Among patients with AKI, 694 died (35%), 519 (26%) were discharged and 780 (39%) were still hospitalized. AKI occurs frequently among patients with Covid-19 disease. It occurs early and in temporal association with respiratory failure and is associated with a poor prognosis.
Keywords: AKI; COVID-19; continuous RRT; dialysis; renal failure.
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Figures






Comment in
-
Diabetes begünstigt Nierenversagen bei COVID-19-Patienten : Corona-Pandemie -- Autor: E. Fritschka.MMW Fortschr Med. 2020 Oct;162(18):31. doi: 10.1007/s15006-020-4481-x. MMW Fortschr Med. 2020. PMID: 33074500 Free PMC article. Review. German. No abstract available.
-
The authors reply.Kidney Int. 2020 Nov;98(5):1348-1349. doi: 10.1016/j.kint.2020.07.048. Kidney Int. 2020. PMID: 33126980 No abstract available.
-
Time-dependent effect, immortal bias, and competing risk: 3 components that should be handled to assess the impact of covariates on occurrence of acute kidney injury.Kidney Int. 2020 Nov;98(5):1348. doi: 10.1016/j.kint.2020.07.049. Kidney Int. 2020. PMID: 33126981 No abstract available.
-
Wayne State University Nephrology service experience in the constraint of COVID-19.Ther Apher Dial. 2021 Dec;25(6):1012-1013. doi: 10.1111/1744-9987.13632. Epub 2021 Mar 13. Ther Apher Dial. 2021. PMID: 33528080 Free PMC article. No abstract available.
Dataset use reported in
-
Role of pediatric nephrologists in managing adults with AKI due to COVID-19.Pediatr Nephrol. 2020 Nov;35(11):2019-2022. doi: 10.1007/s00467-020-04680-7. Epub 2020 Jun 25. Pediatr Nephrol. 2020. PMID: 32588224 Free PMC article. No abstract available.
References
-
- World Health Organization Novel coronavirus—China. January 2020. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ Available at:
-
- COVID-19 Dashboard by the Center for Systems Science and Engineering at Johns Hopkins University. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594... Available at: - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous